KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to 0.15%.

  • Charles River Laboratories International's Return on Invested Capital rose 300.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.02% for FY2024, which is 1400.0% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Return on Invested Capital stood at 0.15%, which was up 300.0% from 0.14% recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Return on Invested Capital ranged from a high of 0.21% in Q2 2022 and a low of 0.04% during Q1 2025
  • Its 5-year average for Return on Invested Capital is 0.15%, with a median of 0.16% in 2023.
  • Over the last 5 years, Charles River Laboratories International's Return on Invested Capital had its largest YoY gain of 300bps in 2025, and its largest YoY loss of -1700bps in 2025.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Return on Invested Capital stood at 0.2% in 2021, then decreased by -7bps to 0.18% in 2022, then decreased by -19bps to 0.15% in 2023, then crashed by -88bps to 0.02% in 2024, then surged by 777bps to 0.15% in 2025.
  • Its Return on Invested Capital was 0.15% in Q3 2025, compared to 0.14% in Q2 2025 and 0.04% in Q1 2025.